Pandemic Planning |
|
 Sign Up for Updates |
|
ABOUT RELENZAHow to Use RELENZA Step-by-StepIt’s vital that all your employees correctly use RELENZA, click here for a step-by-step guideline to correct usage. Please visit the RELENZA Indications and Important Safety Information section for details about the effects of RELENZA and for information about the risk of breathing difficulties. BEFORE YOU START:Please review the About RELENZA section for important information about the effects of RELENZA including the section "Important Safety Information About RELENZA" for information about the risk of breathing difficulties.If RELENZA is prescribed for a child, dosing should be supervised by an adult who understands how to use RELENZA and has been instructed in its use by a healthcare provider. Learn more about your DISKHALER Step A: Load the medicine into the DISKHALER
|
|||||||||||||||||||||||
Keep DISKHALER Level for Steps B and C |
 |
Step C: Inhale
 |
Step D: Move the medicine disk to the next blister
for the next inhalation
 |
Repeat Steps B and C to get your full dose of medicine.
Important Instructions
| • | Read your entire leaflet before using RELENZA. Even if you have had a previous prescription for RELENZA, read the leaflet to see if any information has changed. |
| • | The usual dose is 2 inhalations. However, you must take the number of inhalations your healthcare provider has prescribed. |
| • | If you feel worse or develop new symptoms during or after treatment, or if your flu symptoms do not start to improve, stop using the medicine and contact your healthcare provider. |
| • | Keep out of reach of children. |
| • | Always check inside the mouthpiece to make sure it is clear before each use. If foreign objects are in the mouthpiece, they could be inhaled and cause serious harm. |
| • | Always replace the cover after each use. |
| • | Throw away the DISKHALER after treatment is completed. |
| • | This DISKHALER is for use only with RELENZA. Do not use the RELENZA DISKHALER device with FLOVENT® (fluticasone propionate) and do not use RELENZA with the FLOVENT DISKHALER device. |
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to
REMEMBER: This medicine has been prescribed for you by your healthcare provider. DO NOT give this medicine to anyone else.
next:
Parts of the DISKHALER
Important Safety Information About RELENZA
RELENZA IS NOT RECOMMENDED FOR TREATMENT OR PROPHYLAXIS OF INFLUENZA IN INDIVIDUALS WITH UNDERLYING AIRWAY DISEASE (SUCH AS ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE).
- Serious cases of bronchospasm, including fatalities, have been reported during treatment with RELENZA in patients with and without underlying airway disease. Many of these cases were reported during postmarketing, and causality was difficult to assess
- RELENZA SHOULD BE DISCONTINUED IN ANY PATIENT WHO DEVELOPS BRONCHOSPASM OR DECLINE IN RESPIRATORY FUNCTION; immediate treatment and hospitalization may be required
- Safety and efficacy have not been demonstrated in patients with high-risk underlying medical conditions
- Patients should be instructed in the use of the delivery system. Instructions should include a demonstration whenever possible
- If treatment with RELENZA is considered for a patient with underlying airway disease, the potential risks and benefits should be carefully weighed. If a decision is made to prescribe RELENZA for such a patient, this should be done only under conditions of careful monitoring of respiratory function, close observation, and appropriate supportive care including availability of fast-acting bronchodilators
- Common adverse events in treatment and prophylaxis studies with RELENZA were nausea, diarrhea, sinusitis, viral respiratory infections, headaches, nasal signs and symptoms. The incidence of these adverse events was similar in both groups for RELENZA and placebo-treated groups
- Please see complete Prescribing Information for RELENZA
|
This site is intended for US residents only. © 1997-2008 GlaxoSmithKline. All Rights Reserved. |